FDx Advisors’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
FDx Advisors's RGEN Position: Q2 2024 in Review
FDx Advisors sold out of Repligen (RGEN) in Q2 2024, closing a stake of 1,734 shares — an estimated $319K sold.
FDx Advisors first reported a position in RGEN in Q2 2023 and held it in 3 quarters. The position peaked at $319K in Q1 2024. 455 funds tracked by Wall St. Rank hold RGEN as of Q2 2024.
- FDx Advisors reported no remaining Repligen position as of Q2 2024 after selling out during the quarter.
- FDx Advisors sold 1,734 Repligen shares in Q2 2024, an estimated $319K.
- FDx Advisors first reported a position in Repligen in Q2 2023 and held it in 3 quarters.
- FDx Advisors's Repligen position peaked at $319K in Q1 2024.
- 455 funds tracked by Wall St. Rank held Repligen as of Q2 2024.
Based on FDx Advisors's 13F filing for Q2 2024, filed 2 Aug 2024.